Red Door Wealth Management’s AstraZeneca AZN Stock Holding History

Red Door Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+1,343	New	+$253K	0.02%	278
2024 Q1	–	Sell	-1,676	Closed	-$226K	–	199
2023 Q4	$226K	Sell	1,676 -10	-0.6%	-$1.3K	0.05%	180
2023 Q3	$228K	Buy	+1,686	New	+$230K	0.06%	161
2021 Q3	–	Sell	-507	Closed	-$60K	–	190
2021 Q2	$60K	Buy	+507	New	+$55.6K	0.02%	241
2020 Q3	–	Sell	-43	Closed	-$4K	–	128
2020 Q2	$4K	Hold	43	–	–	﹤0.01%	373
2020 Q1	$3K	Buy	+43	New	+$4.05K	﹤0.01%	370

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Red Door Wealth Management's AZN Position: Q2 2026 in Review

Red Door Wealth Management opened a new position in AstraZeneca (AZN) in Q2 2026: 1,343 shares worth $255K. The stake represents 0.02% of the portfolio and ranks #278 among its holdings. This is a return to the name: Red Door Wealth Management previously reported a position in AZN as recently as Q4 2023.

Red Door Wealth Management first reported a position in AZN in Q1 2020 and has held it in 6 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Red Door Wealth Management held 1,343 shares of AstraZeneca worth $255K as of Q2 2026.
AstraZeneca was a new Red Door Wealth Management position in Q2 2026.
AstraZeneca made up 0.02% of Red Door Wealth Management's portfolio in Q2 2026, its #278 holding.
Red Door Wealth Management first reported a position in AstraZeneca in Q1 2020 and has held it in 6 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.